Søby, Sebastian, et al. “Efficacy of Nivolumab As Second Line Treatment for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A National DAHANCA Cohort Study”. Acta Oncologica, vol. 61, no. 8, Aug. 2022, pp. 972-8, doi:10.1080/0284186X.2022.2103387.